Phase-transfer catalytic synthesis and hypocholesterolemic activity of thiazino[3,2-a]benzimidazole and its silicon analog

Chemistry of Heterocyclic Compounds

Volumn 43, Issue 2, 2007, Pages 220-224

  Abele, E ^a   Abele, R ^a   Arsenyan, P ^a   Belyakov, S ^a   Veveris, M ^a   Lukevics, E ^a  

^a LATVIAN INSTITUTE OF ORGANIC SYNTHESIS   (Latvia)

Author keywords

Hypocholesterolemic activity; Phase transfer catalysis; Thiazino 3,2 a benzimidazole

Indexed keywords

EID: 34249053923     PISSN: 00093122     EISSN: 15738353     Source Type: Journal    
DOI: 10.1007/s10593-007-0034-9     Document Type: Article

References (29)

1. A. Chimirri, S. Grasso, G. Romeo, and M. Zappala, Heterocycles, 27, 1975 (1988).
2. S. S. Pharmaceutical Company, Ltd., Jpn. Patent 8209787; Chem. Abstr., 96, 217861 (1982).
3. S. S. Pharmaceutical Company, Ltd., Jpn. Patent 6075487; Chem. Abstr., 103, 142015 (1985).
4. J. W. Chern, K. C. Liu, and M. T. Lin, T'ai-wan Yao Hsueh Tsa Chih, 38, 144 (1986); Chem. Abstr., 107, 142015 (1987).
5. K. C. Liu, J. W. Chern, and M. T. Lin, T'ai-wan Yao Hsueh Tsa Chih, 38, 231 (1986); Chem. Abstr., 107, 168471 (1987).
6. P. E. Bender, D. T. Hill, P. H. Offen, K. Razgaitis, O. D. Stringer, B. M. Sutton, D. E. Griswold, M. DiMartino, D. T. Walz, I. Lantos, and C. B. Ladd, J. Med. Chem., 28, 1169 (1985).
7. L. Labanauskas, A. Brukstus, E. Udrinaite, P. Gaidelis, V. Bucinskaite, and V. Dauksas, Pharmazie, 55, 429 (2000).
8. R. Crossley and M. J. Meade, UK Patent 2172285; Chem. Abstr., 107, 39872 (1987).
9. R. Crossley and M. J. Meade, UK Patent 2194230; Chem. Abstr., 109, 93011 (1988).
10. R. Crossley, US Patent 4873237; Chem. Abstr., 112, 198401 (1990).
11. H. A. El-Sherief, A. M. Mahmoud, A. E. Abdel-Rahman, and G. M. El-Naggar, J. Indian Chem. Soc., 60, 58 (1983).
12. S. M. Rida, H. M. Salama, I. M. Labouta, and Y. S. A. Ghany, Pharmazie, 41, 324 (1986).
13. T. U. Rani, M. S. Rao, and V. M. Reddy, Indian J. Heterocycl. Chem., 6, 259 (1997); Chem. Abstr., 127, 149111 (1997).
14. S. J. T. Mao, M. T. Yates, and R. A. Parker, PCT Int. Appl. WO Patent 9515760; Chem. Abstr., 123, 188617 (1995).
15. S. J. T. Mao, M. T. Yates, and R. A. Parker, US Patent 5677291; Chem. Abstr., 127, 346189 (1997).
16. K. Rubina, E. Abele, P. Arsenyan, R. Abele, M. Veveris, and E. Lukevics, Metal-Based Drugs, 8, 85 (2001).
17. E. Abele, K. Rubina, R. Abele, O. Dzenitis, P. Arsenyan, J. Popelis, M. Veveris, D. Meirena, and E. Lukevics, Metal-Based Drugs, 8, 307 (2002).
18. E. Abele, M. Veveris, P. Arsenyans, and E. Lukevics, Latv. J. Chem., 71 (2004).
19. R. Kleina, M. Veveris, D. Meirena, E. Abele, and E. Lukevics, Atherosclerosis Supplements, 5, 27 (2004).
20. G. De Stevens, and J. Halamandaris, J. Amer. Chem. Soc., 79, 5710 (1957).
21. A. K. Bagrii, G. F. Galenko, and P. M. Kochergin, Dopov. Akad. Nauk Ukr. RSR, Ser. B, 801 (1975);
22. Chem. Abstr., 84, 43959 (1976).
23. O. P. Suri, R. K. Khajuria, D. B. Saxena, N. S. Rawat, and C. K. Atal, J. Heterocycl. Chem., 20, 813 (1983).
24. S. Smolinski and A. Czarny, Bull. Chem. Soc. Jpn., 52, 930 (1979).
25. H. J.-M. Dou, M. Ludwikow, P. Hassanaly, J. Kister, and J. Metzger, J. Heterocycl. Chem., 17, 393 (1980).
26. S. Mukherjee, G. Bagavant, V. S. Dighe, and S. Somesekhara, Current Sci. (India), 32, 454 (1963); Chem. Abstr., 59, 15275 (1963).
27. P. Arsenyan, R. Abele, S. Belyakov, E. Abele, and E. Lukevics, Appl. Organomet. Chem., 19, 875 (2005).
28. A. Altomare, M. Burla, M. Camalli, G. Cascarano, C. Giacovazzo, A. Guagliardi, A. Moliterni, and R. Spagna, J. Appl. Cryst., 32, 115 (1999).
29. S. Mackay, C. J. Gilmore, C. Edwards, N. Stewart, and K. Shankland. maXus Computer Program for the Solution and Refinement of Crystal Structures. Bruker Nonius, The Netherlands, MacScience, Japan and the University of Glasgow (1999).